SCHEMBL995526

SCHEMBL995526

NCCCNCCCCCNCCCN

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.93
CA6 P23280 5/20 0.93
CA7 P43166 5/20 0.93
CA9 Q16790 5/20 0.93
CA14 Q9ULX7 5/20 0.93
CA5B Q9Y2D0 5/20 0.93
CA2 P00918 4/20 0.93
CA4 P22748 4/20 0.93
CA5A P35218 4/20 0.93
ALOX15 P16050 3/20 0.93
F13A1 P00488 2/20 0.93
CYP1A2 P05177 2/20 0.93
THPO P40225 2/20 0.93
CASP2 P42575 2/20 0.93
MEN1 O00255 2/20 0.93
RECQL P46063 2/20 0.93
KMT2A Q03164 2/20 0.93
CYP2C19 P33261 1/20 0.93
HSD17B10 Q99714 1/20 0.93
CA3 P07451 3/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6030290 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL6031257 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL11584955 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL14739092 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL6029943 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL14740131 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL12002491 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL8092274 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL14739695 1.00 CA12 (0.93) CA12CA6CA7CA9CA14
SCHEMBL222228 1.00 CA12 (0.93) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119191991-A Bio-based aliphatic polyamine chain extender and preparation method thereof, bio-based spray-type flame-retardant polyurea coating and preparation method and application thereof 埃万弗雷(上海)生物科技有限公司 2024-12-27 CN claimed
US-20230101362-A1 RNA STABILIZATION TEAM MEDICAL LLC 2023-03-30 US claimed
US-20060281820-A1 Lfa-1 inhibitors and use thereof SODA KUNIYASU 2006-12-14 US claimed
US-6172261-B1 BIOSYNTHESIS USING CHAIN EXTENSION ORIDIGM CORPORATION 2001-01-09 US claimed
US-20260125344-A1 POLYURETHANE-ACETOACETATE COMPOUNDS PPG INDUSTRIES OHIO, INC. (US) 2026-05-07 US disclosed
EP-3802850-B1 DEVICES AND SYSTEMS FOR GASTROINTESTINAL MICROBIOME DETECTION AND MANIPULATION BT BIDCO INC (US) 2025-11-19 EP disclosed
CN-119191991-B Bio-based aliphatic polyamine chain extender and preparation method thereof, bio-based spray-type flame-retardant polyurea coating and preparation method and application thereof 埃万思创(上海)生物材料有限公司 2025-10-10 CN disclosed
US-20250072427-A1 INSECT ATTRACTANT AND KILLING SYSTEM SUTERRA LLC (US) 2025-03-06 US disclosed
US-20250000364-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS GLAS USA LLC 2025-01-02 US disclosed
US-12178210-B2 Insect attractant and killing system SUTERRA, LLC (US) 2024-12-31 US disclosed
CN-119191991-A Bio-based aliphatic polyamine chain extender and preparation method thereof, bio-based spray-type flame-retardant polyurea coating and preparation method and application thereof 埃万弗雷(上海)生物科技有限公司 2024-12-27 CN disclosed
CN-119191991-A Bio-based aliphatic polyamine chain extender and preparation method thereof, bio-based spray-type flame-retardant polyurea coating and preparation method and application thereof 埃万弗雷(上海)生物科技有限公司 2024-12-27 CN disclosed
EP-1407785-A1 MEDICINAL COMPOSITIONS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2004-04-14 EP disclosed
US-6689919-B1 SOLUBLE POLY(OXYFLUOROPHENYLENE) COMPOUNDS WITH EXCELLENT HEAT RESISTANCE, MEMBRANE-FORMABILITY AND CHEMICAL STABILITY JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2004-02-10 US disclosed
US-6646149-B1 Derivitives of spermine or its N12-t-butyl carbamate VERMEULIN NICOLAAS M J (US) 2003-11-11 US disclosed
US-20030118539-A1 Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy WISCONSIN ALUMNI RESEARCH FOUNDATION 2003-06-26 US disclosed
WO-2003013245-A1 POLYAMINES AND ANALOGS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2003-02-20 WO disclosed
EP-0725149-B1 METHOD OF DETECTING NUCLEIC ACID FUSO PHARMACEUTICAL IND (JP) 2002-01-09 EP disclosed
US-5824474-A Method for detecting nucleic acid FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-10-20 US disclosed
EP-0725149-A1 METHOD OF DETECTING NUCLEIC ACID FUSO PHARMACEUTICAL INDUSTRIES LTD. (JP) 1996-08-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250000364-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS FABP2, SI, MLNR CA12 188/4885CA6 161/4885CA7 466/4885
US-20260125344-A1 POLYURETHANE-ACETOACETATE COMPOUNDS HAT1, PUF60, GAR1 CA12 801/4885CA6 810/4885CA7 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.